ACTIVE SUBSTANCE / INN

LASMIDITAN

Brand name(s): Rayvow, LASMIDITAN

FDA LISTED

EMA LISTED

AUTHORISED

NONE (TENTATIVE APPROVAL)

Migraine Disorders

ANDA219669

ACTIVE SUBSTANCE

Lasmiditan

REGULATORS

FDA · EMA

SPONSORS / MAH

HUMANWELL PHARMACEUTICAL US INC, Eli Lilly Nederland B.V.

TOTAL APPLICATIONS

FDA APPLICATIONS (DRUGS@FDA)

BRAND NAME	APPLICATION	SPONSOR	STATUS
LASMIDITAN	ANDA219669	HUMANWELL PHARMACEUTICAL US INC	None (Tentative Approval)

EMA AUTHORISATIONS

PRODUCT NAME	HOLDER	STATUS	DATE	INDICATION
Rayvow	Eli Lilly Nederland B.V.	Authorised	17/08/2022	Migraine Disorders

FULL INTELLIGENCE ON LASMIDITAN